Common use of Follow-Up Care Clause in Contracts

Follow-Up Care. Includes Home Health Services; home infusion services; and Transplant- related outpatient services rendered within 365 days from the date of the Transplant. For the purposes of this section, the following will be considered to be one Transplant Occurrence: • Bone Marrow/Stem Cell Transplant • Multiple organs replaced during one Transplant surgery • Tandem Transplants (Stem Cell) • Sequential Transplants • Re-Transplant of same organ type within 365 days of the first Transplant • Any other single organ Transplant, unless otherwise excluded under the coverage The following will be considered to be more than one Transplant Occurrence: • Autologous Blood/Bone Marrow Transplant followed by Allogenic Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Allogenic Blood/Bone Marrow Transplant followed by an Autologous Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Re-Transplant after 365 days of the first Transplant • Pancreas Transplant following a kidney Transplant • A Transplant necessitated by an additional organ failure during the original Transplant surgery/process. • More than one Transplant when not performed as part of a planned tandem or sequential Transplant, (e.g. a liver Transplant with subsequent heart Transplant).

Follow-Up Care. Includes Home Health Services; home infusion services; and Transplant- Transplant-related outpatient services rendered within 365 days from the date of the Transplant. For the purposes of this section, the following will be considered to be one Transplant Occurrence: •  Heart  Lung  Heart/ Lung  Simultaneous Pancreas Kidney (SPK)  Pancreas  Kidney  Liver  Intestine  Bone Marrow/Stem Cell Transplant •  Multiple organs replaced during one Transplant surgery • Surgery  Tandem Transplants (Stem Cell) •  Sequential Transplants •  Re-Transplant of same organ type within 365 days of the first Transplant •  Any other single organ Transplant, unless otherwise excluded under the coverage The following will be considered to be more than one Transplant Occurrence: •  Autologous Blood/Bone Marrow Transplant followed by Allogenic Blood/Bone Marrow Transplant (when not part of a tandem Transplant) •  Allogenic Blood/Bone Marrow Transplant followed by an Autologous Blood/Bone Marrow Transplant (when not part of a tandem Transplant) •  Re-Transplant after 365 days of the first Transplant •  Pancreas Transplant following a kidney Transplant •  A Transplant necessitated by an additional organ failure during the original Transplant surgerySurgery/process. •  More than one Transplant when not performed as part of a planned tandem or sequential Transplant, (e.g. a liver Transplant with subsequent heart Transplant).

Follow-Up Care. Includes Home Health Services; , home infusion services; services and Transplant- Transplant-related outpatient services rendered within 365 days from the date of the Transplant. For the purposes of this section, the following will be considered to be one Transplant Occurrence: • Bone Marrow/Stem Cell Transplant • Multiple organs replaced during one Transplant surgery • Tandem Transplants (Stem Cell) • Sequential Transplants • Re-Transplant transplant of same organ type within 365 days of the first Transplant • Any other single organ Transplant, unless otherwise excluded under the coverage coverage. The following will be considered to be more than one Transplant Occurrence: • Autologous Blood/Bone Marrow Transplant followed by Allogenic Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Allogenic Blood/Bone Marrow Transplant followed by an Autologous Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Re-Transplant transplant after 365 days of the first Transplant • Pancreas Transplant following a kidney Transplant • A Transplant necessitated by an additional organ failure during the original Transplant surgery/process. • More than one Transplant when not performed as part of a planned tandem or sequential Transplant, (e.g. a liver Transplant with subsequent heart Transplant).

Follow-Up Care. Includes Home Health Services; home infusion services; and Transplant- related outpatient services rendered within 365 days from the date of the Transplant. For the purposes of this section, the following will be considered to be one Transplant Occurrence: • Bone Marrow/Stem Cell Transplant • Multiple organs replaced during one Transplant surgery • Tandem Transplants (Stem Cell) • Sequential Transplants • Re-Transplant of same organ type within 365 days of the first Transplant • Any other single organ Transplant, unless otherwise excluded under the coverage coverage. The following will be considered to be more than one Transplant Occurrence: • Autologous Blood/Bone Marrow Transplant followed by Allogenic Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Allogenic Blood/Bone Marrow Transplant followed by an Autologous Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Re-Transplant after 365 days of the first Transplant • Pancreas Transplant following a kidney Transplant • A Transplant necessitated by an additional organ failure during the original Transplant surgery/process. • More than one Transplant when not performed as part of a planned tandem or sequential Transplant, (e.g. a liver Transplant with subsequent heart Transplant).

Follow-Up Care. Includes Home Health Services; home infusion services; and Transplant- related outpatient services rendered within 365 days from the date of the Transplant. For the purposes of this section, the following will be considered to be one Transplant Occurrence: • Bone Marrow/Stem Cell Transplant • Multiple organs replaced during one Transplant surgery • Tandem Transplants (Stem Cell) • Sequential Transplants • Re-Transplant of same organ type within 365 180 days of the first Transplant • Any other single organ Transplant, unless otherwise excluded under the coverage The following will be considered to be more than one Transplant Occurrence: • Autologous Blood/Bone Marrow Transplant followed by Allogenic Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Allogenic Blood/Bone Marrow Transplant followed by an Autologous Blood/Bone Marrow Transplant (when not part of a tandem Transplant) • Re-Transplant after 365 180 days of the first Transplant • Pancreas Transplant following a kidney Transplant • A Transplant necessitated by an additional organ failure during the original Transplant surgery/process. • More than one Transplant when not performed as part of a planned tandem or sequential Transplant, (e.g. a liver Transplant with subsequent heart Transplant).